Universal Ibogaine Valuation
| IBOGF Stock | USD 0 0 40.00% |
Universal Ibogaine seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Universal Ibogaine from inspecting the company fundamentals such as Return On Equity of -1.06, current valuation of 4.25 M, and Shares Owned By Insiders of 9.51 % as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Universal Ibogaine's price fluctuation is out of control at this time. Calculation of the real value of Universal Ibogaine is based on 3 months time horizon. Increasing Universal Ibogaine's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Universal pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Universal Ibogaine. Since Universal Ibogaine is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Universal Pink Sheet. However, Universal Ibogaine's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.003 | Real 0.00288 | Hype 0.003086 | Naive 0.002776 |
The real value of Universal Pink Sheet, also known as its intrinsic value, is the underlying worth of Universal Ibogaine Company, which is reflected in its stock price. It is based on Universal Ibogaine's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Universal Ibogaine's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Universal Ibogaine helps investors to forecast how Universal pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Universal Ibogaine more accurately as focusing exclusively on Universal Ibogaine's fundamentals will not take into account other important factors: About Universal Ibogaine Valuation
The pink sheet valuation mechanism determines Universal Ibogaine's current worth on a weekly basis. Our valuation model uses a comparative analysis of Universal Ibogaine. We calculate exposure to Universal Ibogaine's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Universal Ibogaine's related companies.Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada. It undertakes planned clinical trial for research into the use of ibogaine for addiction treatment. Universal Ibogaine is traded on OTC Exchange in the United States.
8 Steps to conduct Universal Ibogaine's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Universal Ibogaine's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Universal Ibogaine's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Universal Ibogaine's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Universal Ibogaine's revenue streams: Identify Universal Ibogaine's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Universal Ibogaine's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Universal Ibogaine's growth potential: Evaluate Universal Ibogaine's management, business model, and growth potential.
- Determine Universal Ibogaine's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Universal Ibogaine's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Universal Ibogaine Growth Indicators
Investing in growth stocks can be very risky. If the company such as Universal Ibogaine does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 190.7 M | |
| Retained Earnings | -22.7 M |
Complementary Tools for Universal Pink Sheet analysis
When running Universal Ibogaine's price analysis, check to measure Universal Ibogaine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Universal Ibogaine is operating at the current time. Most of Universal Ibogaine's value examination focuses on studying past and present price action to predict the probability of Universal Ibogaine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Universal Ibogaine's price. Additionally, you may evaluate how the addition of Universal Ibogaine to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |